Vaxiion Therapeutics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vaxiion Therapeutics, Inc..The latest application filed is for "immunomodulatory minicells and methods of use".

Company Profile

0.9.13

Vaxiion Therapeutics, Inc. - San Diego CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Regulated genetic suicide mechanism compositions and methods Grant 9,045,761 - Giacalone , et al. June 2, 2	2015-06-02
Minicell based delivery of biologically active compounds Grant 9,017,986 - Sabbadini , et al. April 28, 2	2015-04-28
Immunomodulatory Minicells And Methods Of Use App 20140093954 - Giacalone; Matthew J.	2014-04-03
Minicell Based Delivery Of Biologically Active Compounds App 20130337545 - SABBADINI; ROGER ; et al.	2013-12-19
Immunogenic minicells and methods of use Grant 8,524,484 - Sabbadini , et al. September 3, 2	2013-09-03
Regulated Genetic Suicide Mechanism Compositions And Methods App 20130210121 - Giacalone; Matthew J. ; et al.	2013-08-15
Immunogenic Minicells And Methods Of Use App 20120252099 - Sabbadini; Roger A. ; et al.	2012-10-04
Therapeutic Compositions And Methods For Antibody And Fc-containing Targeting Molecule-based Targeted Delivery Of Bioactive Molecules By Bacterial Minicells App 20120207754 - Giacalone; Matthew J. ; et al.	2012-08-16
Minicell Based Delivery Of Biologically Active Compounds App 20120142079 - Sabbadini; Roger A. ; et al.	2012-06-07
Minicell Based Delivery Of Biologically Active Compounds App 20120135503 - Sabbadini; Roger A. ; et al.	2012-05-31
Immunogenic minicells and methods of use Grant 8,129,166 - Sabbadini , et al. March 6, 2	2012-03-06
Minicells displaying antibodies or derivatives thereof and comprising biologically active compounds Grant 8,101,396 - Sabbadini , et al. January 24, 2	2012-01-24
Minicells Expressing Antibodies Or Derivatives Thereof And Comprising Biologically Active Compounds App 20110281330 - Sabbadini; Roger A. ; et al.	2011-11-17
Rhamnose-inducible expression constructs and methods Grant 7,871,815 - Sabbadini , et al. January 18, 2	2011-01-18
Regulated Genetic Suicide Mechanism Compositions And Methods App 20100112670 - Giacalone; Matthew J. ; et al.	2010-05-06
Immunogenic Minicells And Methods Of Use App 20090011490 - Sabbadini; Roger A. ; et al.	2009-01-08
Minicells As Vaccines App 20090004744 - Surber; Mark W. ; et al.	2009-01-01
Immunogenic minicells and methods of use Grant 7,396,822 - Sabbadini , et al. July 8, 2	2008-07-08
Eubacterial minicells and their use as vectors for nucleic acid delivery and expression Grant 7,183,105 - Sabbadini , et al. February 27, 2	2007-02-27

Company Registrations

NCAGE Code	47N62	VAXIION THERAPEUTICS INC
CAGE Code	47N62	VAXIION THERAPEUTICS INC
S.A.M. Registration	47N62 [611020996]	VAXIION THERAPEUTICS INC
DUNS	611020996	Vaxiion Therapeutics Inc

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.